EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer

Jing Sun iD, Jianhui Zhao, Siyun Zhou, Xinxuan Li, Tengfei Li, Lijuan Wang, Shuai Yuan iD, Dong Chen, Philip J Law, Susanna C Larsson, Susan M Farrington, Richard S Houlston und 3 weitere

JNCI: Journal of the National Cancer Institute · 2024

DOI: 10.1093/jnci/djae089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Jing Sun und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Big Data in Health Science School of Public Health, and Center of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zh…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Genome-Wide Association Study, Quantitative Trait Loci, Mendelian Randomization Analysis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Fund for Distinguished Young Scholars of Zhejiang Province, National Nature Science Foundation of China, Swedish Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We aimed to identify plasma and urinary metabolites related to colorectal cancer (CRC) risk and elucidate their mediator role in the associations between modifiable risk factors and CRC.

Methods

Metabolite quantitative trait loci were derived from 2 published metabolomics genome-wide association studies, and summary-level data were extracted for 651 plasma metabolites and 208 urinary metabolites. Genetic associations with CRC were obtained from a large-scale genome-wide association study meta-analysis (100 204 cases, 154 587 controls) and the FinnGen cohort (4957 cases, 304 197 controls). Mendelian randomization and colocalization analyses were performed to evaluate the causal roles of metabolites in CRC. Druggability evaluation was employed to prioritize potential therapeutic targets. Multivariable Mendelian randomization and mediation estimation were conducted to elucidate the mediating effects of metabolites on the associations between modifiable risk factors and CRC.

Results

The study identified 30 plasma metabolites and 4 urinary metabolites for CRC. Plasma sphingomyelin and urinary lactose, which were positively associated with CRC risk, could be modulated by drug interventions (ie, olipudase alfa, tilactase). Thirteen modifiable risk factors were associated with 9 metabolites, and 8 of these modifiable risk factors were associated with CRC risk. These 9 metabolites mediated the effect of modifiable risk factors (Actinobacteria, body mass index, waist to hip ratio, fasting insulin, smoking initiation) on CRC.

Conclusion

This study identified key metabolite biomarkers associated with CRC and elucidated their mediator roles in the associations between modifiable risk factors and CRC. These findings provide new insights into the etiology and potential therapeutic targets for CRC and the etiological pathways of modifiable environmental factors with CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsGenome-Wide Association StudyQuantitative Trait LociMendelian Randomization AnalysisHumansRisk FactorsMetabolomicsBiomarkers, TumorMaleFemaleCase-Control StudiesMetabolomePolymorphism, Single Nucleotide

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Big Data in Health Science School of Public Health, and Center of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

ORCID-Profile: Jing Sun, Shuai Yuan, Xue Li

Förderung

  • Natural Science Fund for Distinguished Young Scholars of Zhejiang Province
  • National Nature Science Foundation of China
  • Swedish Cancer Society
  • Swedish Heart-Lung Foundation
  • Hjärt-Lungfonden
  • Swedish Research Council
  • Vetenskapsrådet
  • CRUK Career Development

Zitieren

APA

Sun, J., Zhao, J., Zhou, S., Li, X., Li, T., Wang, L., Yuan, S., Chen, D., Law, P. J., Larsson, S. C., Farrington, S. M., Houlston, R. S., Dunlop, M. G., Theodoratou, E., & Li, X. (2024). Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae089

Vancouver

Sun J, Zhao J, Zhou S, Li X, Li T, Wang L, et al. Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae089

BibTeX
@article{Sun2024,
  author = {Sun, Jing and Zhao, Jianhui and Zhou, Siyun and Li, Xinxuan and Li, Tengfei and Wang, Lijuan and Yuan, Shuai and Chen, Dong and Law, Philip J and Larsson, Susanna C and Farrington, Susan M and Houlston, Richard S and Dunlop, Malcolm G and Theodoratou, Evropi and Li, Xue},
  title = {Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2024},
  doi = {10.1093/jnci/djae089}
}
Kostenlos starten →